000 | 01746 a2200517 4500 | ||
---|---|---|---|
005 | 20250517100547.0 | ||
264 | 0 | _c20170825 | |
008 | 201708s 0 0 eng d | ||
022 | _a1523-5866 | ||
024 | 7 |
_a10.1093/neuonc/now086 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChang, Ken | |
245 | 0 | 0 |
_aMultimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab. _h[electronic resource] |
260 |
_bNeuro-oncology _c12 2016 |
||
300 |
_a1680-1687 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aBevacizumab _xtherapeutic use |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 |
_aBrain Neoplasms _xdiagnostic imaging |
650 | 0 | 4 |
_aDiffusion Magnetic Resonance Imaging _xmethods |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlioblastoma _xdiagnostic imaging |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImage Interpretation, Computer-Assisted |
650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultimodal Imaging _xmethods |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTumor Burden |
700 | 1 | _aZhang, Biqi | |
700 | 1 | _aGuo, Xiaotao | |
700 | 1 | _aZong, Min | |
700 | 1 | _aRahman, Rifaquat | |
700 | 1 | _aSanchez, David | |
700 | 1 | _aWinder, Nicolette | |
700 | 1 | _aReardon, David A | |
700 | 1 | _aZhao, Binsheng | |
700 | 1 | _aWen, Patrick Y | |
700 | 1 | _aHuang, Raymond Y | |
773 | 0 |
_tNeuro-oncology _gvol. 18 _gno. 12 _gp. 1680-1687 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/neuonc/now086 _zAvailable from publisher's website |
999 |
_c26087003 _d26087003 |